Prof.dr. H.G.M. Leufkens

Update Persondata

• drugs
• epidemiology
• orphan
• pharmaco
• pharmacovigilance

Active as

Publications

(the most recent at the top)

A cohort study exploring determinants of safety-related regulatory actions for biopharmaceuticals

The role of Periodic Safety Update Reports in the safety management of biopharmaceuticals

Today's challenges in pharmacovigilance: what can we learn from epoetins?

Asthma therapy during the first 8 years of life: a PIAMA cohort study

What drives prescribing of asthma medication to children? A multilevel population-based study

All publications..

Enhanced publications

(the most recent at the top)

Doctoral Thesis: New drugs in general practice: prescribing patterns and external influences

Doctoral Thesis: Drug effects on the risk and prognosis of community-acquired pneumonia

Doctoral Thesis: Children and asthma medication : When is that inhaler just a breath away?

Doctoral Thesis: The context of medicines’ use in benefit-risk evaluation

Doctoral Thesis: Markers for disease severity : pharmacoepidemiological studies on obstructive lung disease

All enhanced publications..

Current research

(the most recent research is at the top)
Project leader	Pharmacoepidemiology
Researcher	Towards safe and effective use of medication: prediction scores for major fracture risk assessment in the general elderly population and in elderly patients with rheumatoid arthritis
Project leader	The Escher Project : Science driven drug regulation and innovative research throughout phased drug development
Project leader	Population-based studies of drug treatment

Completed research projects

(the most recent research is at the top)
Project leader	The (future) post-marketing phase: requirements and opportunities for better SAFETY research
Project leader	The quality of post marketing surveillance of biotech drugs
Project leader	Facilitating drug development by creating the ?ideal? regulatory environ­ment in the context of priority medicines
Supervisor	Children and asthma medication – When is that inhaler just a breath away?
Supervisor	The context of medicines’ use in benefit-risk evaluation

All completed research..

Classification

D23110	Infections, parasitology
D23340	Biopharmacology, toxicology